Uprimny, Christian http://orcid.org/0000-0001-5588-3363
von Guggenberg, Elisabeth
Svirydenka, Anna
Mikołajczak, Renata
Hubalewska-Dydejczyk, Alicja
Virgolini, Irene Johanna
Article History
Received: 21 June 2020
Accepted: 15 July 2020
First Online: 3 August 2020
Compliance with ethical standards
: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee. Written informed consent was given by the patient prior to the exams together with the permission for anonymised publication of the related medical data. [<sup>68</sup>Ga]Ga-DOTA-MGS5 was used on a named patient basis and prepared according to the Austrian Medicinal Products Act (AMG §8 and §62).
: The Medical University of Innsbruck has filed a patent application for minigastrin analogues with “Improved pharmacokinetics and cholecystokinin-2 receptor (CCK2R) targeting for diagnosis and therapy”. All other authors have nothing to disclose.